Business Standard

Shukra Pharmaceuticals standalone net profit declines 77.78% in the September 2021 quarter

Image

Capital Market

Sales rise 77.38% to Rs 2.98 crore

Net profit of Shukra Pharmaceuticals declined 77.78% to Rs 0.02 crore in the quarter ended September 2021 as against Rs 0.09 crore during the previous quarter ended September 2020. Sales rose 77.38% to Rs 2.98 crore in the quarter ended September 2021 as against Rs 1.68 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales2.981.68 77 OPM %-64.7720.83 -PBDT0.450.45 0 PBT0.080.09 -11 NP0.020.09 -78

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 30 2021 | 5:27 PM IST

Explore News